OPG、RANK、RANKL的结构、作用机制和在骨疾病中的作用

破骨细胞和成骨细胞分别介导骨的吸收过程和合成过程,而OPG、RANK、RANKL在调节二者的比例中发挥非常重要的作用.RANKL与RANK结合后可能通过三种途径:JNK途径、NF-κB途径和蛋白激酶B途径参与破骨细胞的分化,促进骨质的吸收;RANKL与OPG结合后能阻断RANKL与RANK的结合,由于缺乏RANKL-RANK产生的转录活化信号,破骨细胞分化成熟发生障碍,骨质的吸收受到抑制.OPG、RANK、RANKL同时也是免疫分子,在淋巴细胞、淋巴器官的分化、发育中起重要的作用,骨疾病与免疫系统之间存在着一定的关系.RANMKL/RANK与RANKI/OPG在生物体内保持着一定的比率,如果比率失衡,就会引起各种骨疾病.本篇综述总结了近年来OPG、RANK、RANKL结构、作用的新进展以及它们在骨疾病中的作用.     

中药防治假体周围骨溶解的研究进展

现如今人工关节置换术越来越多的应用于重建关节功能改善关节疾病患者的生活质量,但是术后并发症严重影响了手术的效果,人工假体周围骨溶解及假体无菌性松动又是人工关节置换术后失败的主要原因之一,所以如何预防以及发病后如何去治疗成为现今关节医生面临的重要课题。OPG/RANKL/RANK系统,炎性因子的产生,破骨细胞、成骨细胞这些都是影响人工假体术后产生无菌性松动,和引发假体周围骨溶解的重要因素,有效药物的干预治疗成为现如今关节置换术后以及围手术期的热门话题,中药因其副作用小,疗效独特,及深入的研究逐渐受到广大医生的注意,因此中药在治疗人工假体松动及骨溶解方面也得到了重大突破,本文从中医肾藏精,精生髓,髓能养骨理论着手总结中药作用于OPG/RANKL/RANK系统,抑制炎性因子、破骨细胞及促进成骨细胞增殖的研究现状。     

microRNAs在骨形成中的作用——运动调控骨代谢的新机制

microRNAs(miRNAs)是一类具有组织或发育阶段特异性的小分子、非编码单链RNA,通过转录后与靶基因特定序列结合来发挥其调控作用. 作为骨中的最重要的两种重要细胞--成骨细胞和破骨细胞,其代谢平衡与骨形成密切相关.研究发现,miRNAs在调节成骨细胞和破骨细胞分化及功能发挥上具有重要作用,并且运动训练可通过调节miRNAs进而调控骨细胞分化. 一般来说,适宜强度运动训练可上调某些miRNAs表达来促进成骨细胞或破骨细胞分化及功能;当失重或过量运动时,则会产生抑制作用. 本文就miRNAs调控干细胞向成骨细胞和破骨细胞分化及功能发挥的分子生物学机制以及运动训练调节与骨代谢相关miRNAs表达的研究进展进行综述.     

破骨细胞在类风湿性关节炎骨破坏中的作用及其调控机制

类风湿性关节炎 (RA)是一种严重的慢性炎症性疾病 ,关节软骨及骨的破坏是患者致残的主要原因。近年大量相关研究表明 ,破骨细胞 (OC)在RA骨破坏的病理过程中起关键作用。多种细胞因子参与了对OC生成、活化的调控。其中起正调控作用的主要有IL 1、TNFα、RANKL、M CSF、IL 6、IL 8、IL 17、IL 7、IL 11、IL 15等 ,起负调控作用的有OPG、IL 4、IL 10、IL 12、IL 13、IL 18、IFN λ等。OC及其调控因子的研究为RA骨破坏的治疗提供了一些潜在的靶点 ,具有重要的理论意义和实用价值     

EPO/EPOR-JAK2-STAT5信号传导通路在成釉细胞瘤中表达意义的研究

目的:促红细胞生成素(EPO)及其受体(EPOR)具有促进细胞分裂、生存、肿瘤血管新生以及肿瘤细胞的侵润和转移等多种生物学功能.EPO/EPOR激活的蛋白酪氨酸激酶-2(JAK2)、信号转导子和转录激活子5(STAT5)这一信号传导通路导致头颈部鳞癌的侵润,但在成釉细胞瘤中的作用尚不明确.本文将探讨EPO/EPOR-JAK2-STAT5信号通路在AB中的表达及意义,进一步探索AB的发病机制.方法:应用免疫组化法检测9例牙胚(TG)、10例牙源性角化囊肿(OKC)和36例成釉细胞瘤(AB)中上述四种蛋白的表达.结果:EPO在TG和OKC两组之间免疫组化表达水平存在显著性差异(P＜0.05);EPOR在OKC分别与TG组、AB组间比较,差异具有显著型(P＜0.05).EPOR在AB的无细胞变异亚型分别与棘皮瘤亚型、颗粒细胞亚型之间比较有显著差异(P＜0.05).JAK2在细胞浆、细胞核中的表达,在TG、OKC、AB三组间比较均有显著性差异(P＜0.05)(P＜0.01);在细胞变异亚型、棘皮瘤亚型、颗粒细胞亚型之间比较有极显著差异或显著差异(P＜0.001) (P＜0.01).STAT5在细胞浆、细胞核中的表达,OKC组分别与TG组、AB组比较,均有显著性差异(P＜0.05).结论:EPO/EPOR-JAK2-STAT5信号通路在TG组、OKC组、AB组之间,以及AB的各分型、亚型之间,表达显著差异.研究结果表明,EPO/EPOR在牙源性组织、瘤样病变、AB中通过JAK2-STAT5信号途径发挥作用,EPO/EPOR-JAK2-STAT5通路的异常活化与成釉细胞瘤的发生、发展有关.     

基于OPG/RANK/RANKL信号通路探讨铁筷子对CIA大鼠骨破坏的防护作用

目的 探讨铁筷子对胶原诱导性关节炎(collagen induced arthritis, CIA)模型大鼠的抗炎作用及对OPG/RANK/RANKL信号通路的影响。方法 雌性Wistar大鼠60只分为：正常组、模型组、阳性药物组(甲氨蝶呤,MTX)、低剂量组、中剂量组和高剂量组。采用胶原抗体诱导法于大鼠尾根部注射牛Ⅱ型胶原蛋白建立CIA大鼠模型,模型建立成功后进行灌胃给药,正常组：给予10 mL/(kg·d)生理盐水;模型组：给予10 mL/(kg·d)生理盐水;阳性药物组每次给予2.0 mL/(kg·d) MTX,每周3次;铁筷子低、中、高剂量组每次分别给予0.25 g/(kg·d)、 0.5 g/(kg·d)、1.0 g/(kg·d);连续灌胃治疗25 d。通过记录大鼠体重;观察大鼠足肿胀程度;大鼠踝关节炎指数评分;micro-CT观察踝关节骨组织病理改变;苏木素-伊红(HE)染色对大鼠踝关节骨组织和滑膜病理变化;抗酒石酸酸性磷酸酶(TRAP)染色法检测观察破骨细胞数量的改变;PCR检测骨保护素(OPG)、核因子-κB受体激活剂(RANK)、RANK配体(RANKL)、肿瘤坏死因...     

BTK在粪肠球菌介导的炎症环境中的破骨作用

目的 在粪肠球菌脂磷壁酸（LTA）作用的炎症环境下,研究布鲁顿酪氨酸激酶（BTK）在破骨细胞中的作用,从而为根尖周炎的治疗提供实验依据。方法 PCR检测粪肠球菌LTA刺激破骨细胞后BTK基因水平的表达情况。以浓度300 ng/mL的人重组蛋白BTK（recombinant human BTK,rhBTK）刺激破骨细胞,用CCK8法检测破骨细胞增殖和RT-PCR检测破骨细胞分化标志因子TRAP基因水平表达情况。结果 破骨前体细胞5 d诱导成功。PCR结果发现粪肠球菌LTA刺激后BTK和TRAP的mRNA表达量明显增高;免疫荧光可见LTA刺激后BTK在破骨细胞中的定位情况;300 ng/mL rhBTK组可以促进破骨细胞增殖;PCR结果显示,加入rhBTK后,破骨细胞分化标志因子TRAP的mRNA水平升高。结论 在粪肠球菌LTA作用的炎症环境下,BTK表达升高;增高BTK后,可以促进破骨细胞的增殖及分化。研究发现BTK参与了破骨细胞的炎症反应进程。     

MRI 在脊柱骨巨细胞瘤诊疗中的临床意义

目的:探讨MRI在脊柱骨巨细胞瘤诊疗中的临床应用价值。方法:回顾性分析2005年4月-2010年11月我院5例经病理证实为脊柱骨巨细胞瘤患者的MRI检查表现。结果:椎体内病灶呈不同程度膨胀性破坏,T1WI呈等、低信号改变,T2WI呈混杂信号,增强扫描呈不同程度均匀强化。结论:MRI能有效显示骨巨细胞瘤的病变部位及范围,。     

钙敏感受体在骨代谢中的研究进展

钙敏感受体感受细胞外的钙离子水平,调控一系列激素的释放以维持机体的钙稳态。钙稳态的调节过程与骨代谢相偶联,钙敏感受体通过直接或间接对破骨和成骨细胞的调控,动员或者抑制骨钙入血。虽然钙敏感受体已被证实调控骨代谢,但是详尽的调控机制仍在不断探究中。目前认为细胞外的高钙水平会激活钙敏感受体,抑制甲状旁腺激素分泌并促进降钙素释放,进而破骨细胞被抑制,成骨细胞动员,增加了骨质合成。本文就近年来关于钙敏感受体调控骨代谢的研究进展作一综述,为促进钙敏感受体及相关作用因子治疗骨代谢疾病的研究提供参考。     

成纤维细胞生长因子在骨修复中的作用和应用

成纤维细胞生长因子 ( FGF)是一类与肝素有高亲和性的多聚肽 ,最初根据它能刺激成纤维细胞再生而命名。现已发现有 1 8个成员 ,即 FGF1- FGF18。目前研究得最多的是 FGF1和 FGF2 。根据它们等电点 ( PI)的不同 ,FGF1又称为酸性成纤维细胞生长因子 ( a FGF,PI为 5 .6) ,FGF2 又称为碱性成纤维细胞生长因子 ( b FGF,PI为 9.6) ,它们均通过自分泌和 /或旁分泌途径在组织修复中发挥重要作用。成纤维细胞生长因子受体 ( FGFR)属于免疫球蛋白超家族成员 ,目前已确定了 4种由独立基因编码的人 FGFR。它们是一种跨膜蛋白质 ,分为细…     

核因子-KB在腹部火器伤肠管穿透后肺组织细胞凋亡中的作用

目的：探讨腹部火器伤肠管穿透后核因子-κB在肺组织细胞凋亡中的作用,了解腹部火器伤肠管穿透后继发性肺损伤机制。方法：健康长白仔猪42头随机等分为对照组和伤后1h、2h、4h、8h、12h和24h组,实验组建立腹部火器伤肠管穿透模型后,用免疫组化图像分析法测定各组肺组织内NF-κB活性,同时用TUNEL测定肺组织细胞凋亡变化情况。结果：伤后各组肺组织内NF-κB活性明显高于对照组,并于伤后8h出现高峰。肺组织细胞凋亡指数伤后显著增高（P〈0.05）,并与NF-κB活性变化基本一致。结论：腹部火器伤肠管穿透后肺组织内NF-κB活性增强,肺细胞凋亡增多,从而继发导致肺损伤     

肺癌CT征象与核因子-kappa B表达

目的:观察肺癌的核因子-kappa B(NF-κB)表达水平与CT影像的特点,探讨二者之间的相关性.方法:收集未经任何治疗的80例周围型肺癌及19例炎症占位组织学标本,采用免疫组织化学streptavidin peroxide(S-P)法检测NF-κB的核内表达水平.同时收集所有病变的CT图像资料,观察肿瘤的影像学特点并进行记录.首先分析NF-κB表达在良恶性占位中有无差异,再分析在不同病理类型的肺癌中有无差异.然后以肿块大小(直径≤5cm组和＞5cm组)、有无毛刺、分叶、坏死、转移这五个特点各分为两组,并就各组对应的NF-κB表达进行分析.结果:NF-κB在肺癌中表达明显高于在炎症病变中的表达,而在不同病理类型的肺癌中的表达无差异.CT表现有毛刺、已有转移者标本中NF-κB表达较没有毛刺及未发生转移组高;瘤体有坏死者表达较没有坏死者低.肿瘤大小组间及有无分叶之间其NF-κB表达未见明显差异.结论:NF-κB在肺癌中表达明显高于在炎症病变中的表达,对应的CT征像有其特点,可能与肺癌的浸润及转移相关.     

核因子-κB 在腹部火器伤肠管穿透后肺组织细胞凋亡中的作用*

目的:探讨腹部火器伤肠管穿透后核因子-κB在肺组织细胞凋亡中的作用,了解腹部火器伤肠管穿透后继发性肺损伤机制。方法:健康长白仔猪42头随机等分为对照组和伤后1h、2h、4h、8h、12h和24h组,实验组建立腹部火器伤肠管穿透模型后,用免疫组化图像分析法测定各组肺组织内NF-κB活性,同时用TUNEL测定肺组织细胞凋亡变化情况。结果:伤后各组肺组织内NF-κB活性明显高于对照组,并于伤后8h出现高峰。肺组织细胞凋亡指数伤后显著增高(P<0.05),并与NF-κB活性变化基本一致。结论:腹部火器伤肠管穿透后肺组织内NF-κB活性增强,肺细胞凋亡增多,从而继发导致肺损伤。     

Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica

Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-κB), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-κB was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-κB signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-κB activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-κB signaling) in HSCs opposed those of NF-κB signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-κB signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-κB signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.     

Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo

Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties that is currently being examined in clinical trials to prevent and treat various diseases, including atherosclerosis, stroke, and cancer. However, no reports are available for verifying the pharmacological effects of ebselen on major metabolic bone diseases such as osteoporosis. In this study, we observed that ebselen suppressed the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells in an osteoblast/osteoclast co-culture by regulating the ratio of receptor activator of nuclear factor kappa-B ligand (RANKL)/osteoprotegerin secreted by osteoblasts. In addition, ebselen treatment in the early stage of osteoclast differentiation inhibited RANKL-dependent osteoclastogenesis by decreasing the phosphorylation of IκB, PI3K, and Akt in early signaling pathways and by subsequently inducing c-Fos and nuclear factor of activated T-cells c1. Further, ebselen induced apoptosis of osteoclasts in the late stage of osteoclast differentiation. In addition, ebselen treatment suppressed filamentous actin ring formation and bone resorption activity of mature osteoclasts. Reflecting these in vitro effects, administration of ebselen recovered bone loss and its µ-CT parameters in lipopolysaccharide-mediated mouse model. Histological analysis confirmed that ebselen prevented trabecular bone matrix degradation and osteoclast formation in the bone tissues. Finally, it was proved that the anti-osteoclastogenic action of ebselen is achieved through targeting N-methyl-D-aspartate (NMDA) receptor. These results indicate that ebselen is a potentially safe drug for treating metabolic bone diseases such as osteoporosis.     

NF-κB在溃疡性结肠炎中的作用

核因子NF-κB(Nuclear factor kappa-B,NF-κB)是一种多向性的转录因子,它参与多种炎症和免疫应答相关分子基因的表达,同时也参与调控细胞的增殖和分化。它在动脉粥样硬化、关节炎、哮喘、肿瘤等疾病的发展中都起了重要的作用。炎症是多种细胞及细胞因子参与的机体防御性反应,但严重或长期的炎症则会造成机体损伤。溃疡性结肠炎(UC)是一组以慢性、周期性炎症为特征的肠道疾病,长期、反复的肠道炎症不仅影响患者生活质量,而且增加了肠道纤维化及癌变的风险,而核因子NF-κB与炎症反应关系非常密切。本文就NF-κB的作用与UC的联系作一简要综述。     

Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis

Obesity-induced endoplasmic reticulum (ER) stress has been proposed as an important pathway in the development of insulin resistance. Protein-tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling and is tethered to the ER-membrane. The aim of the study was to determine the mechanisms involved in the crosstalk between ER-stress and PTP1B. PTP1B whole body knockout and C57BL/6J mice were subjected to a high-fat or normal chow-diet for 20 weeks. High-fat diet feeding induced body weight gain, increased adiposity, systemic glucose intolerance, and hepatic steatosis were attenuated by PTP1B deletion. High-fat diet- fed PTP1B knockout mice also exhibited improved glucose uptake measured using [³H]-2-deoxy-glucose incorporation assay and Akt phosphorylation in the skeletal muscle tissue, compared to their wild-type control mice which received similar diet. High-fat diet-induced upregulation of glucose-regulated protein-78, phosphorylation of eukaryotic initiation factor 2α and c-Jun NH₂-terminal kinase-2 were significantly attenuated in the PTP1B knockout mice. Mice lacking PTP1B showed decreased expression of the autophagy related protein p62 and the unfolded protein response adaptor protein NCK1 (non-catalytic region of tyrosine kinase). Treatment of C2C12 myotubes with the ER-stressor tunicamycin resulted in the accumulation of reactive oxygen species (ROS), leading to the activation of protein expression of PTP1B. Furthermore, tunicamycin-induced ROS production activated nuclear translocation of NFκB p65 and was required for ER stress-mediated expression of PTP1B. Our data suggest that PTP1B is induced by ER stress via the activation of the ROS-NFκB axis which is causes unfolded protein response and mediates insulin resistance in the skeletal muscle under obese condition.     

Elevated Cerebral Cortical CD24 Levels in Patients and Mice with Traumatic Brain Injury: A Potential Negative Role in Nuclear Factor Kappa B/Inflammatory Factor Pathway

Increasing evidence indicates that sterile inflammatory response contributes to secondary brain injury following traumatic brain injury (TBI). However, the specific mechanisms remain largely unknown, as is whether CD24, known as an important regulator in the non-infectious inflammatory response, plays a role in secondary brain injury after TBI. Here, the expression of CD24 was detected in samples from patients with TBI by quantitative real-time polymerase chain reaction (PCR), western blotting, immunohistochemistry and immunofluorescence. RNA interference was used to investigate the effects of CD24 on inflammatory response in a mouse model of TBI. Nuclear factor kappa B (NF-κB) DNA-binding activity was measured by electrophoretic mobility shift assay, and the levels of downstream pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and Interleukin 1β (IL-1β) were detected by real-time PCR. The results indicated that both the mRNA and protein levels of CD24 were markedly elevated after TBI in humans and mice, showing a time-dependent expression. The expression of CD24 could be observed in neurons, astrocytes and microglia in both humans and mice. Meanwhile, downregulation of CD24 significantly induced an increase of NF-κB DNA-binding activity and mRNA levels of TNF-α and IL-1β. These findings indicated that CD24 expression could negatively regulate the NF-κB/inflammatory factor pathway after experimental TBI in mice, thus providing a novel target for therapeutic intervention of TBI.     

Resorption Controls Bone Anabolism Driven by Parathyroid Hormone (PTH) Receptor Signaling in Osteocytes

The contribution of remodeling-based bone formation coupled to osteoclast activity versus modeling-based bone formation that occurs independently of resorption, to the anabolic effect of PTH remains unclear. We addressed this question using transgenic mice with activated PTH receptor signaling in osteocytes that exhibit increased bone mass and remodeling, recognized skeletal effects of PTH elevation. Direct inhibition of bone formation was accomplished genetically by overexpressing the Wnt antagonist Sost/sclerostin; and resorption-dependent bone formation was inhibited pharmacologically with the bisphosphonate alendronate. We found that bone formation induced by osteocytic PTH receptor signaling on the periosteal surface depends on Wnt signaling but not on resorption. In contrast, bone formation on the endocortical surface results from a combination of Wnt-driven increased osteoblast number and resorption-dependent osteoblast activity. Moreover, elevated osteoclasts and intracortical/calvarial porosity is exacerbated by overexpressing Sost and reversed by blocking resorption. Furthermore, increased cancellous bone is abolished by Wnt inhibition but further increased by blocking resorption. Thus, resorption induced by PTH receptor signaling in osteocytes is critical for full anabolism in cortical bone, but tempers bone gain in cancellous bone. Dissecting underlying mechanisms of PTH receptor signaling would allow targeting actions in different bone compartments, enhancing the therapeutic potential of the pathway.     

Effect of Carbon Monoxide-Releasing Molecules II-liberated CO on Suppressing Inflammatory Response in Sepsis by Interfering with Nuclear Factor Kappa B Activation

Sepsis continues to be a challenge in clinic. The rates of mortality in sepsis patients remain high. The present study aimed to investigate the effects and the underlying mechanisms of carbon monoxide-releasing molecules II (CORM-2)-liberated CO on suppressing inflammatory response in sepsis. It was shown that treatment of septic mice with CORM-2 attenuated PMN accumulation, downregulated cytokines production, inhibited expressions of iNOS and NF-κB activity in the lung and liver. In parallel, CORM-2 prevented activation of NF-κB in LPS-stimulated HUVEC. This was accompanied by a decrease in ROS and NO production, expression of ICAM-1 and subsequent PMN adhesion to HUVEC. These findings demonstrated that CORM-released CO attenuates inflammatory responses by interfering with NF-κB activation and therefore decreasing the expression of ICAM-1 and NO production, attenuating the oxidative stress and inflammation in sepsis.